Wenchi Shang

1.6k total citations
22 papers, 1.3k citations indexed

About

Wenchi Shang is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, Wenchi Shang has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 11 papers in Pharmacology and 9 papers in Infectious Diseases. Recurrent topics in Wenchi Shang's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Wenchi Shang is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Wenchi Shang collaborates with scholars based in United States, Switzerland and Belgium. Wenchi Shang's co-authors include Karen Bush, Thomas D. Gootz, Todd A. Davies, Anne Marie Queenan, Fadia B. Dib-Hajj, Robert K. Flamm, Malcolm G. P. Page, Malgosia Kania, Karen Amsler and Frank S. Kaczmarek and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Biochemical Pharmacology.

In The Last Decade

Wenchi Shang

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenchi Shang United States	18	876	462	462	344	266	22	1.3k
María‐Isabel Morosini Spain	26	946 1.1×	295 0.6×	446 1.0×	259 0.8×	459 1.7×	55	1.6k
Belén Aracil Spain	23	843 1.0×	245 0.5×	491 1.1×	181 0.5×	188 0.7×	54	1.3k
Jennifer Adams United States	12	955 1.1×	273 0.6×	375 0.8×	188 0.5×	365 1.4×	13	1.3k
M Visalli United States	20	946 1.1×	613 1.3×	538 1.2×	292 0.8×	370 1.4×	32	1.6k
Michael Kresken Germany	21	669 0.8×	426 0.9×	474 1.0×	448 1.3×	272 1.0×	73	1.4k
María Eugenia Pachón-Ibáñez Spain	23	1.0k 1.2×	410 0.9×	330 0.7×	191 0.6×	521 2.0×	65	1.6k
Qinglan Guo China	23	1.3k 1.4×	378 0.8×	446 1.0×	215 0.6×	319 1.2×	57	1.6k
Yih‐Ru Shiau Taiwan	23	813 0.9×	182 0.4×	389 0.8×	418 1.2×	401 1.5×	32	1.5k
María García-Castillo Spain	22	842 1.0×	314 0.7×	322 0.7×	161 0.5×	291 1.1×	40	1.2k
Fabrice Compain France	18	650 0.7×	190 0.4×	437 0.9×	309 0.9×	229 0.9×	42	1.2k

Countries citing papers authored by Wenchi Shang

Since Specialization

Citations

This map shows the geographic impact of Wenchi Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchi Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchi Shang more than expected).

Fields of papers citing papers by Wenchi Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenchi Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchi Shang. The network helps show where Wenchi Shang may publish in the future.

Co-authorship network of co-authors of Wenchi Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenchi Shang. A scholar is included among the top collaborators of Wenchi Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenchi Shang. Wenchi Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Queenan, Anne Marie, et al.. (2014). The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccines. Expert Review of Vaccines. 13(10). 1265–1270. 7 indexed citations

Pawloski, Lucia C., Anne Marie Queenan, Pamela K. Cassiday, et al.. (2013). Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States. Clinical and Vaccine Immunology. 21(2). 119–125. 161 indexed citations

Abbanat, Darren, et al.. (2013). Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays. International Journal of Antimicrobial Agents. 43(1). 32–39. 31 indexed citations

Fernandez, Jeffrey, Darren Abbanat, Wenchi Shang, et al.. (2012). Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56(3). 1476–1484. 24 indexed citations

Davies, Todd A., Anne Marie Queenan, Brian J. Morrow, et al.. (2011). Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09. Journal of Antimicrobial Chemotherapy. 66(10). 2298–2307. 80 indexed citations

Morrow, Brian J., Darren Abbanat, Ellen Z. Baum, et al.. (2011). Antistaphylococcal Activities of the New Fluoroquinolone JNJ-Q2. Antimicrobial Agents and Chemotherapy. 55(12). 5512–5521. 23 indexed citations

Papp‐Wallace, Krisztina M., Christopher R. Bethel, Thomas D. Gootz, et al.. (2011). Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone. Biochemical Pharmacology. 83(4). 462–471. 16 indexed citations

Queenan, Anne Marie, Wenchi Shang, Karen Bush, & Robert K. Flamm. (2010). Differential Selection of Single-Step AmpC or Efflux Mutants of Pseudomonas aeruginosa by Using Cefepime, Ceftazidime, or Ceftobiprole. Antimicrobial Agents and Chemotherapy. 54(10). 4092–4097. 25 indexed citations

Davies, Todd A., Wenchi Shang, Karen Amsler, et al.. (2009). Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials. International Journal of Antimicrobial Agents. 34(2). 166–168. 7 indexed citations

10.

Queenan, Anne Marie, Wenchi Shang, Robert K. Flamm, & Karen Bush. (2009). Hydrolysis and Inhibition Profiles of β-Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem. Antimicrobial Agents and Chemotherapy. 54(1). 565–569. 84 indexed citations

11.

Shang, Wenchi, Todd A. Davies, Robert K. Flamm, & Karen Bush. (2009). Effects of Ceftobiprole and Oxacillin on mecA Expression in Methicillin-Resistant Staphylococcus aureus Clinical Isolates. Antimicrobial Agents and Chemotherapy. 54(2). 956–959. 13 indexed citations

12.

Amsler, Karen, Todd A. Davies, Wenchi Shang, Michael R. Jacobs, & Karen Bush. (2008). In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 52(9). 3418–3423. 30 indexed citations

13.

Kamicker, Barbara J., et al.. (2007). Bacterial Efflux Pump Inhibitors. Methods in molecular medicine. 142. 187–204. 27 indexed citations

14.

Dib-Hajj, Fadia B., Lucinda Lamb, Frank S. Kaczmarek, et al.. (2007). Enterococcal virulence determinants may be involved in resistance to clinical therapy. Diagnostic Microbiology and Infectious Disease. 58(1). 59–65. 49 indexed citations

15.

Davies, Todd A., et al.. (2007). Binding of Ceftobiprole and Comparators to the Penicillin-Binding Proteins of Escherichia coli , Pseudomonas aeruginosa , Staphylococcus aureus , and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 51(7). 2621–2624. 139 indexed citations

16.

Davies, Todd A., Wenchi Shang, & Karen Bush. (2006). Activities of Ceftobiprole and Other β-Lactams against Streptococcus pneumoniae Clinical Isolates from the United States with Defined Substitutions in Penicillin-Binding Proteins PBP 1a, PBP 2b, and PBP 2x. Antimicrobial Agents and Chemotherapy. 50(7). 2530–2532. 32 indexed citations

17.

Lomaestro, Ben M., Ellis Tobin, Wenchi Shang, & Thomas D. Gootz. (2006). The Spread ofKlebsiella pneumoniaeCarbapenemase–ProducingK. pneumoniaeto Upstate New York. Clinical Infectious Diseases. 43(3). e26–e28. 93 indexed citations

18.

Dib-Hajj, Fadia B., et al.. (2006). High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla _ACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrobial Agents and Chemotherapy. 50(10). 3396–3406. 204 indexed citations

19.

Queenan, Anne Marie, Wenchi Shang, Paul C. Schreckenberger, et al.. (2006). SME-3, a Novel Member of the Serratia marcescens SME Family of Carbapenem-Hydrolyzing β-Lactamases. Antimicrobial Agents and Chemotherapy. 50(10). 3485–3487. 35 indexed citations

20.

Kaczmarek, Frank S., et al.. (2004). Genetic and Molecular Characterization of β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae with Unusually High Resistance to Ampicillin. Antimicrobial Agents and Chemotherapy. 48(5). 1630–1639. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact